Total Solution of Novel Coronavirus 2019-nCoV Nucleic Acid Detection

NMPA CERTIFICATE

Total Solution of Novel Coronavirus 2019-nCoV Nucleic Acid Detection

Solution1

Sampling

Nucleic Acid Extraction

Real Time PCR Amplification

· Highly Sensitive· Fully Automatic

Quick Nucleic Acid Detection Solution (Based on One-Step method)

Free of Nucleic Acid Extraction

· Rapid· Simple· Economical

Solution2

Automatic Nucleic Acid Extraction & Detection Solution

Real Time PCR Amplification

Fast Sample Release· Automatic Nucleic Acid Extraction System (Extractor & Kits)· 10min for extraction

· No Extractor· Only 30s operation to obtain nucleic acid

Uni-medica provides a high-throughput and rapid solution for screening and detecting COVID-19 during medical observation and in suspected population. It includes:

· Disposable Virus Sampling Kits.· Automatic Nucleic Acid Extraction System( Extractor & Kits).· Real Time PCR Amplification System.

Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab, N)

Nucleic Acid Detection Kits

ORF1ab gene

N gene

InternalControl

Advantage

High Accuracy

The product has been approved by the state drug administration and obtained NMPA and CE certification. The kit has been verified by 600+ clinical samples and used in more

than 100 hospitals and Centers for Disease Control and Prevention;

High Sensitivity

Limit of detection is 200 copies/ml;

Internal Control

The whole process is monitored by internal control;

Flexibility

Compatible with multiple brands of Real Time PCR systems;

Rapid Reaction Time

~1.5 hours.

Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab, N, E)

ORF1ab gene

N gene

InternalControl

E gene

Multiplex Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab/Influenza A/Influenza B)

ORF1ab gene

Influenza A

InternalControl

Influenza B

In autumn and winter, it is very important to differential diagnosis influenza and COVID-19 to provide

patients with appropriate treatment. The kit provided by Uni-medica can simultaneously detect the

novel coronavirus 2019-nCoV (ORF1ab), influenza A and influenza B in one tube.

Advantage

High Accuracy

The product has been used in more than 100 hospitals and Centers for Disease Control and Prevention;

High Sensitivity

Limit of detection is 200 copies/ml;

Internal Control

The whole process is monitored by internal control;

Flexibility

Compatible with multiple brands of Real Time PCR systems;

Rapid Reaction Time

~1.5 hours;

High Efficiency

One detection can distinguish influenza A, influenza B and novel coronavirus

2019-nCoV;

High Specificity

No cross reaction with other pathogens, such as SARS-CoV, MERS-CoV, CoV-HKU1,

CoV-229E, CoV-NL63, etc.

Classify patients to avoid

cross infection

Detect COVID-19/FluA/FluB in one tube

Full-component Freeze-drying Technology

Freeze-Dried Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab, N)

And a series of freeze-dried products……

Freeze-drying Technology

Transport and Store at Room Temperature

Greatly Reduce Transportation Costs

Room temperature storageNo need low temperature storage, fully release cold storage space;

1Room temperature transportation Reduce transportation costs;

2

Zero lossAvoid loss of high viscosity components, such as enzyme;

3High convenienceOne-Step: Freeze-dried RT-PCR Mix are prepackaged in 8-strip tubes, only need to add nucleic acid;

4

High accuracyFreeze-dried RT-PCR Mix, avoid repeated freeze-thaw;

5High thermostability37℃ and 55℃ properties are confirmd.

6

Automatic Nucleic Acid Extraction System

Automatic NucleicAcid Extractor

Nucleic AcidExtraction Reagent

High recovery rate of magnetic beads: > 99%;

High capacity of nucleic Acid: >90%;

Rapid: purification of 1~32 samples in one run in 10 minutes;

Open system: nucleic acid extraction reagents and nucleic acid extractor are both open.

1

2

4

Sample Release Reagent

Classic Medium

Pre-loading Plate

Magnetic Bar Sleeve

3

Nucleic acid release reagent

RNA protectant

· To obtain nucleic acid only by one-step operation in 30s.

· Free of nucleic acid extraction.

Simple operation, Rapid processing;

No need to buy any nucleic acid extractors.

Real Time Fluorescence Quantitative PCR System (MA6000)

Products

Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab, N)

DescriptionSpecs

50 tests/kit Analytes: ORF1ab, N gene and Internal control

Multiplex Real Time PCR Kit for Novel Coronavirus 2019-nCoV(ORF1ab)/Influenza A/Influenza B

50 tests/kitAnalytes: Novel coronavirus 2019-nCoV (ORF1ab), Influenza A, Influenza B and Internal control

Disposable Virus Sampling Tube

Automatic Nucleic Acid Extractor (Magnetic Bead Adsorption Method)

ITEM No.

R030

R033

R029

/

50 pcs/kit

M32

PP fiber swabs and Virus sampling tube

Flux: 1~32 samplesExtraction time: 10 minutes

Sample Release Reagent R031 100 tests/kitLysing the virus samples and Release the nucleic acid

Nucleic Acid Extraction Reagent

64 tests/kit, 96 tests/kit, 384 tests/kit, 100 tests/kit,300 tests/kit, 1000 tests/kit

Saliva samples, Sputum, Nasopharyngeal swabs, Oropharyngeal swabs, Bronchoalveolar lavage fluid(BALF), Blood serum and plasma

R024R025

Real Time Fluorescence Quantitative PCR System /MA6000 Flux: 1~96 samples

Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab,N,E)

50 tests/kit Analytes: ORF1ab,N,E gene and Internal control

R034

Flux: 1~96 samples;

6-zone independent temperature control + edge

thermal compensation technology;

5 colors (can be upgraded to 8-color fluorescence);

High sensitivity: low copy samples can be

effectively detected.

SHENZHEN UNI-MEDICA TECHNOLOGY CO., LTDAddress: Block 6th, Liuxian Culture Park of Liuxiandong Village, Nanshan District,

Shenzhen, Guangdong Province, P. R. China

Telephone: 0086-755-86505501

E-mail: marketing@uni-medica.com

UNI-MEDICA

Shenzhen Uni-medica Technology Co., Ltd (Uni-medica) is a national high-tech enterprise. It has established cooperation and jointly performed a number of scientific research projects with the Hong Kong University of Science and Technology, Shenzhen University and Chinese Academy of Sciences. Uni-medica was also selected as one of the top 100 new Chinese innovative enterprises. The company takes the technical innovation of molecular detection methods as the core driving force, and focuses on the R&D and industrialization of molecular diagnostic products aiming at prevention and control of infectious diseases and genetic diseases. Uni-medica provides total solution of accurate diagnosis of infectious diseases and genetic diseases based on multi-omics technologies, including multiplex PCR, NGS technology and flow cytometry. Uni-medica is qualified by ISO 13485 and NMPA quality control system. The pathogen molecular detection products are daily used in hundreds of hospitals, Centers for Disease Control and Prevention and Quarantine Laboratories throughout the country, providing strong support for prevention and control of infectious diseases.